DEUTSCHE BANK AG\ - HEMISPHERX BIOPHARMA INC ownership

HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C301. A total of 21 filers reported holding HEMISPHERX BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of HEMISPHERX BIOPHARMA INC
ValueSharesWeighting
Q3 2018$0626
+2508.3%
0.00%
Q2 2018$0240.0%0.00%
Q4 2017$0240.0%0.00%
Q3 2017$0240.0%0.00%
Q2 2017$0240.0%0.00%
Q1 2017$0240.0%0.00%
Q4 2016$0240.0%0.00%
Q3 2016$0240.00%
Other shareholders
HEMISPHERX BIOPHARMA INC shareholders Q2 2017
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,938,374$620,0000.10%
Occidental Asset Management, LLC 15,834$5,0000.00%
Waldron Private Wealth LLC 11,000$3,0000.00%
VANGUARD GROUP INC 467,574$150,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 1,080$00.00%
UBS Group AG 20,658$7,0000.00%
Advisor Group, Inc. 250$00.00%
Jacobi Capital Management LLC 318$00.00%
HUNTINGTON NATIONAL BANK 2,501$00.00%
CITY HOLDING CO 417$00.00%
View complete list of HEMISPHERX BIOPHARMA INC shareholders